Published • loading... • Updated
Boston Scientific: Q1 Earnings Snapshot
The medical device maker reported $5.2 billion in revenue and 80 cents a share in adjusted profit, then lowered its 2026 outlook.
Summary by Washington Top News
10 Articles
10 Articles
Boston Scientific reports steady Q1 2026 performance yet tempers FY26 outlook
Despite Boston’s Q1 performance denoting a YoY rise of 11.2%, the company has trimmed its full-year growth outlook by 2% at the top-end.The post Boston Scientific reports steady Q1 2026 performance yet tempers FY26 outlook appeared first on Medical Device Network.
Coverage Details
Total News Sources10
Leaning Left0Leaning Right0Center8Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium






